Tumor cells gain the ability to divide indefinitely by bypassing the natural limit that stops normal cells from dividing forever. This process involves telomeres, DNA damage signaling, defective tumor suppressors, and activation of telomere maintenance.

1. Normal cells have a replicative limit

Normal somatic cells cannot divide forever.

They typically undergo about 70 divisions, after which they stop.

This limit is called the Hayflick limit.

Why division stops

Every time a cell divides, the telomeres—protective caps at chromosome ends—shorten.

When telomeres become critically short, the cell interprets this as DNA damage.

This activates DNA damage response pathways involving:

• TP53
• RB

These tumor suppressors trigger senescence:

• a permanent, non-dividing state
• cell remains alive but cannot replicate further

2. If TP53 or RB are mutated (lost)

If the damage checkpoint fails due to TP53 or RB loss, cells continue attempting division.

What does the cell try instead of senescence?

It performs an error-prone repair method:

Non-Homologous End Joining (NHEJ)

This repair:

• stitches broken chromosome ends together without checking whether they match
• can lead to incorrect fusions

Consequences of faulty joining

NHEJ can create dicentric chromosomes:

• one chromosome with two centromeres

During mitosis (anaphase), spindle fibres pull on both ends.

This generates chromosome breakage, beginning:

Bridge–Fusion–Breakage cycles:

1. Bridge = chromosomes fused end-to-end
2. Fusion = incorrect rejoining continues
3. Breakage = chromosomes snap during separation
4. Repeats through successive divisions

This causes extreme genomic instability.

If unrestrained, this instability causes widespread lethal DNA damage, leading to catastrophic mitotic failure for many cells.

3. How tumor cells avoid death from telomere crisis

To prevent repeated chromosome breakage, tumor cells activate a telomere maintenance mechanism.

Main mechanism: reactivation of telomerase

• Telomerase is a reverse transcriptase enzyme
• Adds telomere repeats to chromosome ends
• Restores telomere length
• Prevents fusion and crisis cycles

Normally:

• ON in stem cells + germline cells
• OFF in most adult somatic cells

Frequency in cancers

• 85–95% of cancers use telomerase
• The remaining ~5–15% use ALT (Alternative Lengthening of Telomeres)
• a telomerase-independent recombination-based pathway

By restoring telomeres, tumor cells escape crisis and achieve replicative immortality.

4. Telomere crisis and cancer evolution

Paradoxically, telomere shortening can contribute to cancer development.

Sequence:

1. Early tumor cells divide repeatedly.
2. Telomeres shorten → chromosomes unprotected.
3. Breakage–fusion–breakage cycles occur → large genomic instability.
4. Mutations accumulate, some providing survival advantages.
5. Eventually, telomerase becomes active.
6. Telomeres stabilize → genome freezes in a highly mutated state.
7. This stabilized population proliferates → malignant clone emerges.

Analogy:

• Chaos storm of mutations → once telomerase is turned on, the genome becomes stable → the cell continues dividing with all those advantageous mutations saved.

5. Evidence: colon cancer progression

Studies of colon cancer demonstrate this telomerase model:

• Adenomas (precancerous polyps):
• low telomerase
• high genomic instability
• Adenocarcinomas (invasive cancers):
• high telomerase
• stable but structurally complex chromosomes

This supports the idea that:

• genomic chaos occurs first
• telomerase activation occurs later
• leading to a stabilized malignant cell population

SUMMARY TABLE (no omissions)

One-sentence recall

Short telomeres make normal cells stop dividing; if checkpoint genes fail, DNA repair becomes faulty and chromosomes break repeatedly—cancer cells survive only by turning on telomerase (or ALT) to stabilize telomeres and divide indefinitely, locking in mutation-driven advantages.

🧠 EXAM REFLEX BLOCK — Replicative Immortality (ZERO-OMISSION)

Core trigger

• Progressive telomere shortening occurs with each cell division in normal somatic cells.
• When telomeres become critically short, chromosome ends are sensed as DNA double-strand breaks.

Normal safeguard

• TP53 + RB pathway activation → permanent cellular senescence.
• This enforces the Hayflick limit (~70 divisions).
• Cell remains viable but irreversibly non-dividing.

Checkpoint failure (key cancer step)

• Loss/mutation of TP53 or RB disables senescence.
• Cell continues cycling with uncapped chromosome ends.

Faulty repair mechanism

• Exposed chromosome ends are joined by Non-Homologous End Joining (NHEJ).
• NHEJ is error-prone and ignores sequence homology.

Structural consequence

• Formation of dicentric chromosomes (two centromeres).
• During anaphase → opposing spindle pull → chromosome rupture.

Pathological cycle

• Breakage–Fusion–Bridge (BFB) cycles:
• Breakage → Fusion → Bridge → Re-breakage
• Repeats over multiple divisions.

Biological outcome

• Massive genomic instability:
• Deletions
• Amplifications
• Translocations
• Aneuploidy
• Many cells undergo mitotic catastrophe and death.

Survival bottleneck (crisis)

• Only rare cells escape by activating telomere maintenance.

Escape mechanisms

• Telomerase reactivation (85–95% of cancers)
• Reverse transcriptase
• Adds telomeric repeats
• Prevents further chromosome fusion
• ALT (alternative lenghthening of telomeres)pathway (5–15%)
• Telomerase-independent
• Homologous recombination–based telomere elongation

Physiological contrast

• Telomerase normally ON in:
• Germline cells
• Stem cells
• Telomerase normally OFF in:
• Adult somatic cells

Cancer evolution logic

1. Early proliferation → telomere shortening
2. Checkpoint loss → BFB cycles → genomic chaos
3. Selection of advantageous mutations
4. Telomerase activation → telomere stabilization
5. Genome becomes fixed in a highly mutated but stable state
6. Replicative immortality achieved

Classic evidence (colon cancer)

• Adenoma:
• Low telomerase
• High chromosomal instability
• Adenocarcinoma:
• High telomerase
• Stable but complex karyotype

⚡ ONE-LINE EXAM LOCK

Cancer cells divide indefinitely by bypassing telomere-induced senescence (TP53/RB loss), surviving genomic chaos from breakage–fusion–bridge cycles only after telomerase or ALT stabilizes telomeres, permanently fixing oncogenic mutations.